Physical Sciences and Mathematics Commons^™

Estimating Sensitivity And Specificity From A Phase 2 Biomarker Study That Allows For Early Termination, Margaret S. Pepe Phd

UW Biostatistics Working Paper Series

Development of a disease screening biomarker involves several phases. In phase 2 its sensitivity and specificity is compared with established thresholds for minimally acceptable performance. Since we anticipate that most candidate markers will not prove to be useful and availability of specimens and funding is limited, early termination of a study is appropriate if accumulating data indicate that the marker is inadequate. Yet, for markers that complete phase 2, we seek estimates of sensitivity and specificity to proceed with the design of subsequent phase 3 studies.

We suggest early stopping criteria and estimation procedures that adjust for bias caused by …